Edition:
United States

Rxi Pharmaceuticals Corp (RXII.OQ)

RXII.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
71,210
52-wk High
$1.75
52-wk Low
$0.32

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Bitterman

65 2013 Independence Chairman of the Board

Geert Cauwenbergh

63 2015 President, Chief Executive Officer, acting Chief Financial Officer, Director

Gerrit Dispersyn

2017 Chief Development Officer

Keith Brownlie

64 2013 Independent Director

H. Paul Dorman

79 2013 Independent Director